Levetiracetam vs placeboReduction of of anxiety symptoms ‐ Clinician‐rated: LSAS avoidance subscale · adults with SAnD1 finding from 1 reviewPharmacotherapy for social anxiety disorder (SAnD) 2017 · Cochrane Headline outcomes onlyno estimate extracted1 study · 16 participantsVery low
Benzodiazepines vs placeboReduction of of anxiety symptoms ‐ Clinician‐rated: LSAS avoidance subscale · adults with SAnD1 finding from 1 reviewPharmacotherapy for social anxiety disorder (SAnD) 2017 · Cochrane Headline outcomes onlyno estimate extracted1 study · 75 participantsLow
MAOIs vs placeboReduction of of anxiety symptoms ‐ Clinician‐rated: LSAS avoidance subscale · adults with SAnD1 finding from 1 reviewPharmacotherapy for social anxiety disorder (SAnD) 2017 · Cochrane Headline outcomes onlyno estimate extracted1 study · 51 participantsVery low
Comparison 1: 5HT1A partial agonists vs placeboReduction of of anxiety symptoms ‐ Clinician‐rated: LSAS avoidance subscale · adults with SAnD1 finding from 1 reviewPharmacotherapy for social anxiety disorder (SAnD) 2017 · Cochrane Headline outcomes onlyno estimate extracted1 study · 30 participantsVery low
Comparison 9: NaSSAs vs placeboReduction of of anxiety symptoms ‐ Clinician‐rated: LSAS avoidance subscale · adults with SAnD1 finding from 1 reviewPharmacotherapy for social anxiety disorder (SAnD) 2017 · Cochrane Headline outcomes onlyno estimate extracted1 study · 60 participantsLow
Comparison 10: RIMAs vs placeboReduction of of anxiety symptoms ‐ Clinician‐rated: LSAS avoidance subscale · adults with SAnD1 finding from 1 reviewPharmacotherapy for social anxiety disorder (SAnD) 2017 · Cochrane Headline outcomes onlyno estimate extracted5 studies · 695 participantsLow
Comparison 12: SNRIs vs placeboReduction of of anxiety symptoms ‐ Clinician‐rated: LSAS avoidance subscale · adults with SAnD1 finding from 1 reviewPharmacotherapy for social anxiety disorder (SAnD) 2017 · Cochrane Headline outcomes onlyno estimate extracted1 study · 261 participantsLow
Comparison 13: SSRIs vs placeboReduction of of anxiety symptoms ‐ Clinician‐rated: LSAS avoidance subscale · adults with SAnD1 finding from 1 reviewPharmacotherapy for social anxiety disorder (SAnD) 2017 · Cochrane Headline outcomes onlyno estimate extracted7 studies · 1173 participantsLow
Comparison 2: anticonvulsants/GABAs vs placeboReduction of of anxiety symptoms ‐ Clinician‐rated: LSAS avoidance subscale · adults with SAnD1 finding from 1 reviewPharmacotherapy for social anxiety disorder (SAnD) 2017 · Cochrane Headline outcomes onlyno estimate extracted1 study · 69 participantsLow